LivaNova Financial Ratios
NASDAQ: LIVNHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
LivaNova ratio analysis
LivaNova earned a net margin of -17.5% in FY 2025, down from 5.0% a year earlier. Gross margin was 67.7% compared with a median of 66.8% over the prior 9 years. Return on equity reached -20.2%, meaning LivaNova generated -0.20 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.31 versus 0.48 the year before, and the current ratio was 1.36. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
LivaNova financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | — | 40.75 | 161.69 | — | — | — | — | — | — | — |
| Price / sales | 2.38 | 2.05 | 2.42 | 2.91 | 4.28 | 3.44 | 3.23 | 3.97 | 3.80 | 2.28 |
| Price / book | 2.76 | 1.94 | 2.18 | 2.46 | 3.42 | 2.90 | 2.54 | 2.93 | 2.12 | 1.29 |
| Gross margin | 67.7% | 68.1% | 65.5% | 69.2% | 68.2% | 63.7% | 66.8% | 67.4% | 64.4% | 58.0% |
| Operating margin | 14.4% | 10.3% | -5.9% | -7.5% | -0.1% | -29.3% | -15.8% | -22.4% | 9.5% | 3.5% |
| Net margin | -17.5% | 5.0% | 1.5% | -8.4% | -13.1% | -37.3% | -14.5% | -17.1% | -2.5% | -6.5% |
| Free cash flow margin | 12.5% | 10.8% | 3.5% | 4.2% | 7.4% | -12.3% | -10.7% | 7.5% | 5.8% | 5.4% |
| Return on equity (ROE) | -20.2% | 4.8% | 1.4% | -7.1% | -10.5% | -31.4% | -11.4% | -12.6% | -1.4% | -3.7% |
| Return on assets (ROA) | -9.3% | 2.5% | 0.7% | -3.8% | -6.2% | -14.5% | -6.5% | -7.4% | -1.0% | -2.7% |
| Debt / equity | 0.31 | 0.48 | 0.46 | 0.45 | 0.19 | 0.59 | 0.25 | 0.11 | 0.08 | 0.07 |
| Current ratio | 1.36 | 2.87 | 2.95 | 2.98 | 0.97 | 2.29 | 1.07 | 1.07 | 2.14 | 2.32 |
| Revenue growth | 10.7% | 8.7% | 12.9% | -1.3% | 10.8% | -13.8% | -2.1% | 9.4% | 4.9% | 230.9% |
| EPS growth | -483.6% | 262.5% | — | — | — | — | — | — | — | -159.0% |